Celexa Hair Loss: Risk, Timeline & Fixes

Celexa hair loss (citalopram) is best handled with timeline logic, because most medication-linked hair loss behaves like telogen effluvium (TE): the trigger happens first, and shedding becomes noticeable later. Importantly, the FDA label for Celexa lists alopecia under Skin and Appendages Disorders as an infrequent adverse reaction. The same label defines “infrequent” as occurring in less than 1/100 patients down to 1/1000 in the clinical-trial reporting framework. This does not prove causation in an individual case—but it confirms a real signal that belongs on the differential when timing and pattern fit.

Medical note: This article is for general education and does not provide personal medical advice. Do not stop or change Celexa/citalopram without clinician guidance. If you’re not sure whether you’re seeing shedding or breakage, start here: Shedding vs Breakage. If the diagnosis is unclear, start here: How Hair Loss Is Diagnosed. If you have scalp pain/burning, pustules/crusting, heavy scale, open sores, or rapid worsening, start here: When to See a Doctor.

Celexa hair loss: FDA label alopecia listing (infrequent), TE timing (2–4 months), SSRI median onset 8.6 weeks, pattern clues, labs to consider, and practical next steps. — Most SSRI-linked hair loss fits delayed TE logic. Timing + pattern are the fastest way to avoid misdiagnosis.

Quick navigation

Key takeaways (fast)
What the FDA label actually says (and what it doesn’t)
Timeline: when shedding starts, peaks, and improves
Pattern clues: TE vs AGA vs AA vs breakage
Why timing varies (trigger stacking)
When labs matter (targeted workup)
What to do (practical plan)
When to see a doctor
Related on this site
References

Key takeaways (fast)

FDA label signal: Celexa (citalopram) labeling lists alopecia under Skin and Appendages Disorders as an infrequent adverse reaction.
What “infrequent” means (label definition): less than 1/100 down to 1/1000 in trial reporting categories (not a perfect real-world incidence, but a concrete label framework).
SSRI case literature timing: a 2022 systematic review of SSRI-associated alopecia reports found time-to-onset ranged from 3 days to 5 years with a median of 8.6 weeks, and recovery after stopping the suspected SSRI occurred in 63% of episodes (case-report literature).
TE timing is delayed: DermNet notes increased hair fall is noticed 2 to 4 months after the trigger; BAD notes it can occur around 3 months after a trigger.
Do not self-stop: if Celexa timing is plausible, the right move is clinician-guided risk/benefit + timeline review + alternatives if needed.
Site context: SSRI Hair Loss (Overview) • Lexapro Hair Loss • Prozac Hair Loss • Zoloft Hair Loss • Medication-Related Shedding.

What the FDA label actually says (and what it doesn’t)

What it says: Celexa’s FDA label lists alopecia under “Skin and Appendages Disorders” as infrequent, and defines infrequent adverse reactions as those occurring in less than 1/100 to 1/1000 patients in the trial-reporting framework.

What it does not say: it does not give a clean “true incidence” you can apply to every person in real life. That’s why the most reliable tool becomes pattern + timing.

Timeline: when shedding starts, peaks, and improves

Onset: if Celexa triggers TE, shedding is delayed. DermNet notes increased hair fall is noticed 2 to 4 months after the trigger; BAD notes it can occur around 3 months after a trigger. SSRI case literature shows a median onset of 8.6 weeks (close to the TE window in many real-world cases).
Peak: TE often feels worst for several weeks once it starts.
Recovery: once triggers stabilize (often via clinician-guided med changes + correcting overlaps), shedding typically slows first; density recovery takes longer.

Pattern clues: TE vs AGA vs AA vs breakage

Most consistent with TE: diffuse shedding, normal-looking scalp, delayed timing after starting Celexa or changing dose.
TE + AGA overlap: if shedding slows but the part/crown keeps widening, consider TE unmasking pattern hair loss: TE vs Androgenetic Alopecia.
Patchy smooth bald spots: consider alopecia areata: Alopecia Areata Hub.
Lots of short snapped hairs: consider breakage: Hair Breakage (Hair-Shaft).

Why timing varies (trigger stacking)

In real life, SSRI starts/dose changes often overlap with other TE triggers (illness, stress, dieting/weight change, other new meds). That’s why SSRI hair-loss reports show a wide timing range; treat this as a “trigger stack” investigation, not a one-variable story.

When labs matter (targeted workup)

If shedding is heavy, persistent, or recurrent, clinicians often screen for overlap triggers such as iron status and thyroid issues. Use:

Blood Tests & Workup

What to do (practical plan)

Build a timeline: start date, dose changes, and the exact month shedding became noticeable.
Confirm the pattern: TE vs breakage vs overlap AGA vs AA.
Talk to the prescriber: if timing fits, discuss options (watchful waiting vs dose adjustment vs switch) based on mental-health risk/benefit. Do not self-stop.
Unstack triggers: stabilize nutrition, avoid crash dieting, correct deficiencies if proven.
Track monthly: photos every 4 weeks (same angle/light).

When to see a doctor

Scalp pain/burning, pustules, open sores, heavy scale/crusting
Patchy smooth bald spots
Shedding persisting beyond ~6 months or recurrent waves

Start here: When to See a Doctor.

References (trusted sources)

Last updated: March 07, 2026.